Visus Therapeutics

Updated: September 10, 2025

Founder Benjamin Bergo

Country: USA | Funding: $56M (+)

Visus Therapeutics is a clinical-stage company developing treatment for age-related long-sightedness. Acquired by Tenpoint Therapeutics